William Blair & Company’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.3M | Buy |
126,421
+45,143
| +56% | +$6.92M | 0.06% | 250 |
|
|
2025
Q4 | $11.2M | Buy |
81,278
+15,552
| +24% | +$2.04M | 0.03% | 335 |
|
|
2025
Q3 | $8.43M | Sell |
65,726
-381
| -0.6% | -$46.5K | 0.02% | 403 |
|
|
2025
Q2 | $8M | Sell |
66,107
-10,415
| -14% | -$1.17M | 0.02% | 396 |
|
|
2025
Q1 | $8.53M | Sell |
76,522
-3,730
| -5% | -$397K | 0.03% | 360 |
|
|
2024
Q4 | $7.81M | Sell |
80,252
-567
| -0.7% | -$60.5K | 0.02% | 390 |
|
|
2024
Q3 | $9.3M | Sell |
80,819
-343
| -0.4% | -$38.9K | 0.03% | 356 |
|
|
2024
Q2 | $8.64M | Sell |
81,162
-823
| -1% | -$82.6K | 0.03% | 348 |
|
|
2024
Q1 | $7.93M | Sell |
81,985
-3,266
| -4% | -$335K | 0.02% | 373 |
|
|
2023
Q4 | $8.61M | Buy |
85,251
+560
| +0.7% | +$54.1K | 0.03% | 346 |
|
|
2023
Q3 | $8.63M | Sell |
84,691
-2,292
| -3% | -$233K | 0.03% | 331 |
|
|
2023
Q2 | $8.78M | Sell |
86,983
-1,781
| -2% | -$178K | 0.03% | 336 |
|
|
2023
Q1 | $8.17M | Sell |
88,764
-1,956
| -2% | -$171K | 0.03% | 344 |
|
|
2022
Q4 | $8.23M | Sell |
90,720
-8,130
| -8% | -$685K | 0.04% | 329 |
|
|
2022
Q3 | $7.51M | Sell |
98,850
-100
| -0.1% | -$8.29K | 0.03% | 331 |
|
|
2022
Q2 | $8.36M | Sell |
98,950
-1,215
| -1% | -$107K | 0.04% | 321 |
|
|
2022
Q1 | $8.79M | Sell |
100,165
-884
| -0.9% | -$76.5K | 0.03% | 345 |
|
|
2021
Q4 | $8.84M | Buy |
101,049
+10,304
| +11% | +$856K | 0.03% | 364 |
|
|
2021
Q3 | $7.42M | Sell |
90,745
-4,756
| -5% | -$428K | 0.03% | 378 |
|
|
2021
Q2 | $8.71M | Sell |
95,501
-34,468
| -27% | -$3.07M | 0.03% | 348 |
|
|
2021
Q1 | $11.1M | Sell |
129,969
-23,444
| -15% | -$2.1M | 0.04% | 304 |
|
|
2020
Q4 | $14.5M | Sell |
153,413
-56,204
| -27% | -$4.91M | 0.05% | 249 |
|
|
2020
Q3 | $18.2M | Buy |
209,617
+13,065
| +7% | +$1.13M | 0.08% | 199 |
|
|
2020
Q2 | $17.2M | Sell |
196,552
-12,893
| -6% | -$1.11M | 0.08% | 200 |
|
|
2020
Q1 | $17.3M | Sell |
209,445
-8,234
| -4% | -$735K | 0.11% | 170 |
|
|
2019
Q4 | $20.6M | Buy |
217,679
+42,785
| +24% | +$3.84M | 0.11% | 188 |
|
|
2019
Q3 | $15.2M | Sell |
174,894
-10,595
| -6% | -$951K | 0.09% | 202 |
|
|
2019
Q2 | $16.9M | Sell |
185,489
-15,325
| -8% | -$1.3M | 0.1% | 194 |
|
|
2019
Q1 | $17.3M | Buy |
200,814
+2,194
| +1% | +$176K | 0.11% | 183 |
|
|
2018
Q4 | $15.3M | Buy |
198,620
+3,568
| +2% | +$278K | 0.11% | 178 |
|
|
2018
Q3 | $15.1M | Buy |
195,052
+1,632
| +0.8% | +$121K | 0.09% | 200 |
|
|
2018
Q2 | $13.1M | Sell |
193,420
-7,527
| -4% | -$519K | 0.09% | 209 |
|
|
2018
Q1 | $14.6M | Sell |
200,947
-122,456
| -38% | -$9.32M | 0.1% | 184 |
|
|
2017
Q4 | $24.3M | Buy |
323,403
+119,710
| +59% | +$9.03M | 0.17% | 137 |
|
|
2017
Q3 | $15.7M | Buy |
203,693
+5,724
| +3% | +$432K | 0.12% | 180 |
|
|
2017
Q2 | $14.8M | Buy |
197,969
+30,961
| +19% | +$2.19M | 0.11% | 195 |
|
|
2017
Q1 | $11.2M | Sell |
167,008
-1,136
| -0.7% | -$75.7K | 0.09% | 214 |
|
|
2016
Q4 | $11M | Buy |
168,144
+5,274
| +3% | +$342K | 0.1% | 208 |
|
|
2016
Q3 | $11.5M | Sell |
162,870
-11,690
| -7% | -$852K | 0.1% | 199 |
|
|
2016
Q2 | $12.9M | Sell |
174,560
-15,703
| -8% | -$1.08M | 0.12% | 185 |
|
|
2016
Q1 | $12.3M | Sell |
190,263
-4,700
| -2% | -$320K | 0.12% | 179 |
|
|
2015
Q4 | $15M | Sell |
194,963
-43,812
| -18% | -$3.48M | 0.14% | 163 |
|
|
2015
Q3 | $19.7M | Buy |
238,775
+9,748
| +4% | +$868K | 0.17% | 147 |
|
|
2015
Q2 | $20.2M | Buy |
229,027
+13,341
| +6% | +$1.22M | 0.03% | 641 |
|
|
2015
Q1 | $19.1M | Sell |
215,686
-27,006
| -11% | -$2.4M | 0.03% | 622 |
|
|
2014
Q4 | $20.1M | Buy |
242,692
+13,574
| +6% | +$1.13M | 0.03% | 593 |
|
|
2014
Q3 | $19.3M | Buy |
229,118
+21,852
| +11% | +$1.77M | 0.03% | 582 |
|
|
2014
Q2 | $16.8M | Buy |
207,266
+40,665
| +24% | +$3.2M | 0.03% | 635 |
|
|
2014
Q1 | $12.7M | Buy |
166,601
+4,708
| +3% | +$343K | 0.02% | 737 |
|
|
2013
Q4 | $11.7M | Sell |
161,893
-25,006
| -13% | -$1.74M | 0.02% | 745 |
|
|
2013
Q3 | $12.8M | Sell |
186,899
-60,765
| -25% | -$4.02M | 0.02% | 658 |
|
|
2013
Q2 | $15.7M | Buy |
+247,664
| New | +$16.1M | 0.03% | 550 |
|
Other funds holding NVS
William Blair & Company's NVS Position: Q1 2026 in Review
William Blair & Company increased its Novartis (NVS) stake by 56% in Q1 2026, buying an estimated $6.92M and bringing the position to 126,421 shares worth $19.3M. The position accounts for 0.06% of the portfolio, ranked #250.
William Blair & Company first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.3M in Q4 2017. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- William Blair & Company held 126,421 shares of Novartis worth $19.3M as of Q1 2026.
- William Blair & Company bought 45,143 Novartis shares in Q1 2026, an estimated $6.92M.
- Novartis made up 0.06% of William Blair & Company's portfolio in Q1 2026, its #250 holding.
- William Blair & Company first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- William Blair & Company's Novartis position peaked at $24.3M in Q4 2017.
- 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.